US FTC suspends challenge to block Amgen ' s $27.8 billion deal for Horizon Therapeutics

FILE PHOTO: An Amgen sign is seen at the company's office in South San Francisco (Reuters) -The U.S. Federal Trade Commission (FTC) has suspended its challenge of Amgen's $27.8 billion purchase of Horizon Therapeutics, allowing the FTC to consider whether the agency should settle the case, a…#southsanfrancisco #ftc #amgen #horizontherapeutics #horizon #tepezza #thousandoaks #medicare

Source: Reuters: Health - August 27, 2023 Category: Consumer Health News Source Type: news